Industry
Distribution Agreement Reached for Multiplexed Assay Platforms
Affymetrix and Luminex have announced their agreement under which eBioscience, a business unit of Affymetrix, will sell 3 Lumix xMAP-based instruments for multiplexed assays in specific countries in the Americas, Asia, and Europe, enabling laboratories to choose a platform that fits their throughput and flexibility needs. More...27 Oct 2015
Enhanced IT Propels Clinical Laboratory Services Sector
Fueled by new information technology software that allows laboratories to test in new ways, the USD 102 billion global market for clinical laboratory services is rapidly growing and evolving, according to a new healthcare market report. The growing number of laboratories offering specialty testing is an indication of such advancements in the industry. More...26 Oct 2015
Erba Mannheim Acquires Maxmat for Diagnostics Analyzers and Advanced Development
Through its Czech subsidiary Erba Lachema, Erba Mannheim has expanded its portfolio by acquiring Maxmat SA, France, a company emphasizing development and manufacturing of medical laboratory devices based on original patented technologies. More...25 Oct 2015
Diagnostic Company Acquisition to Ease Market Entry and Shorten Development Time for New Tests
Two North American manufacturers of rapid diagnostic tests are combining in order to pool their products for rapid entry into the diagnostic product market and to boost development of new tests. More...15 Sep 2015
Supply Agreement to Boost Molecular Diagnostic Testing in Scandinavia
One of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services has signed an agreement for the supply of diagnostic products over the next four years for Sweden and Norway with a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases. More...14 Sep 2015
Clinical Applications Transforming Flow Cytometry Sector
Clinical applications of flow cytometry instrumentation and reagents are transforming this market with a high-growth path and emerging active partnerships leveraging increased demand to quantify cell markers, according to a new market analysis. More...06 Sep 2015
Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer
An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. More...30 Aug 2015
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
In Other News
Distribution Agreement to Improve Automated Hemostasis Diagnostics
Innovative Microbial Diagnostics Developer Acquired by Biomedical Giant
Alere Strengthens Core Strategy Through Two New Transactions
Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim
QIAGEN Expands Diagnostics Menu in Partnership with Seegene
Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens
Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics
Cloud-Based Systems Becoming Key Pillar in eHealth Strategy
Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer
New Point of Care Test for Anemia Developed
Main Factors Driving Revenue Growth in Clinical Chemistry Identified
Bio-Rad Grants Beckman Coulter Exclusive Distribution for Two Infectious Disease Tests
Partnership to Offer New Coagulation Testing Solutions Worldwide
Clinical Lab Automation Sector at USD 5.4 Billion and Growing
Beyond Brazil, Latin American IVD Sector Grows
Improved Ebola IVD Tests Continue to Face Challenges
NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer
Microbiologics and Microbix Partner on Viral Controls for Diagnostics
Precision Makes dPCR a Steadily Growing Sector
Philips Collaborates with Janssen on Handheld Test for Neuropsychiatric Disorders
Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads
“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery
Sequencing-Based Testing Sector Already Highly Competitive
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
